Neuland Laboratories Ltd.
NEULANDLAB Share PricePharmaceuticals & Drugs
₹16,995
21 (0.1%)
As on December 4, 2025
Exchange Scrips: BSE524558NSENEULANDLABISININE794A01010
Market Cap ₹ 21,727 Cr
P/E Ratio 83.83
Dividend Yield 0.01 %
Performance
Market performance
Open16,974
High17,230
Volumes55,892
Prev16,995
Low16,798
As on2025-12-04
Historical performance
1 Year High19,747
3 Year High19,747
5 Year High19,747
1 Year Low10,190.7
3 Year Low1,318.1
5 Year Low967
Fundamentals
Company Valuation
Market Cap (₹Cr)
21,727
Face Value (₹)
10
P/E Ratio
83.83
Dividend Yield
0.01 %
Investment Returns
1 Year
-4.5%
3 Years
896.2%
5 Years
1418.1%
10 Years
2336%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 16,839.6 | Bullish |
| 10-DMA | 16,716.8 | Bullish |
| 20-DMA | 17,048.65 | Bearish |
| 50-DMA | 16,321.22 | Bullish |
| 100-DMA | 15,176.57 | Bullish |
| 200-DMA | 13,536.03 | Bullish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 13 | 12 | 12 | 11 | 11 |
| Foreign Investors | 2 | 2 | 2 | 2 | 2 |
| Domestic Investors | 11 | 10 | 10 | 9 | 9 |
| Public Investors | 44380 | 42407 | 39321 | 39304 | 34556 |
| Government | 1 | 1 | 1 | 1 | 1 |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 83.83.
- 3Y Stock Price CAGR of the stock is 115.1.
- The stock has a beta of 1.3.
- In the last financial year, the company had an EBITDA of ₹3438 Million.
- The company generated revenue of ₹14768 Million in the previous financial year.
Neuland Laboratories Ltd.
1699521 (0.1%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 952298.2
No. of Shares: 56 (Approx)
Performance:-4.8%
P/L: ₹-47701.8
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
